DTC Report

Omnicom Group reports income down 13.7% in Q4

Demonstrating just how badly mainline agencies are suffering from the recession, Omnicom Group reported that Q4 net income was down 13.7% to $271 million from $313.9 million for the period a year ago.

Bausch & Lomb launches campaign for Crystalens for cataracts

Bausch & Lomb launched a targeted ad campaign aimed at seniors for its new Crystalens intraocular lens for cataracts.

Nissen comments on DDMAC's needs to restrict DTC

Steven Nissen, head of cardiovascular medicine at Cleveland Clinic, wrote in the journal Nature that DDMAC "needs the right to restrict direct-to-consumer advertising during the first two years a drug is marketed and to preview advertising to ensure it is not misleading."

Social media renders commercial model obsolete: panel

By

To leverage social media effectively, the drug industry will have to transform its commercial model, said panelists at the ePharma Summit.

McGarryBowen lands consumer advertising business for Chantix

By

Pfizer moved the consumer advertising business for Chantix to McGarryBowen, ending McCann HumanCare's contract on the smoking cessation drug.

FDA to test out 1-800-AERS

By

The FDA is weighing requiring DTC TV ads to carry a toll-free number for adverse events reports and is surveying 1,600 consumers to find out what they think, the Associated Press reported.

Roche CEO criticizes TV advertising

By

Consumer advertising "was the single worst decision for the industry," according to Roche Pharmaceuticals CEO William Burns at a conference in London early last month.

DTC spend lagged in '08, says TNS

By

Spending on DTC launch campaigns dropped this year as companies waited longer to market fewer new drugs with more limited indications, said a TNS Media Intelligence report.

Watch those advertising and promo claims, say laywers

By

Attorneys at the Washington law firm of McDermott Will & Emery advised in October that companies wishing to avoid FDA challenges to drug ads and promotional pieces should review their materials in all therapeutic categories to determine whether they make implied outcomes claims.

FDA raps Amgen, Bayer for promos

By

The FDA's Division of Drug Marketing, Advertising and Communications (DDMAC) issued an untitled letter on a patient brochure for Amgen's Sensipar.

Kohl seeks backup for device ads

By

Sen. Herb Kohl (D-WI) said DTC ads for devices should be regulated just as much as those for drugs and called on his colleague in the House, Rep. Bart Stupak (D-MI), to work with him toward that end.

DDMAC warns Bayer on YAZ TV ads

By

The FDA slapped Bayer HealthCare Pharmaceuticals with a warning letter on two 60-second TV ads for its YAZ contraceptive.

FDA posts DTC guide on its site

By

FDA posted a guide to drug advertising on its site for consumers, "Be smart about prescription drug advertising."

Ads in Canada had little impact: study

By

A study of how DTC TV advertising impacted different populations in Canada suggested that ads may have little impact on consumers.

PhRMA sends lawyers to meet with HECC staff

PhRMA sent a delegation of lawyers to meet with House Energy and Commerce Committee staffers to try and head off new regulations and discuss recent work on an update of PhRMA's DTC guidelines.

Warner Chilcott to limit DTC, rely more on reps

Warner Chilcott said it would "make much more limited use of DTC in support of our existing brands," relying instead on reps to drive market share gains

FDA will survey how visuals distract viewers

The FDA will test broadcast-style ads for a bogus blood pressure drug as part of a survey aimed at determining how visuals may distract viewers from risk information.

J&J may consolidate Rx advertising

By

Johnson & Johnson is considering consolidating advertising and marketing for its pharmaceutical brands into one or possibly two companies, a J&J spokesperson told MM&M.

Parade to launch 'healthy' supplement

By

Parade Magazine's monthly health supplement, HealthyStyle, debuts Sept. 17, and the publisher hopes it will prove a lure for pharma advertisers.

Pharmas spent $16 million on DTC in WV, according to report

A report by West Virginia's Pharmaceutical Cost Management Council said pharmas spent $16 million on DTC advertising in the state from July 2007 through December 2007.

Dingell, Stupak praise firms for following AMA guidelines

Reps. John Dingell and Bart Stupak, who chair the Committee on Energy and Commerce and the Oversight and Investigations Subcommittee thereof, respectively, praised Merck, Schering-Plough, Pfizer and J&J for agreeing to follow AMA guidelines regarding the use of docs in ads and to not advertise off-label uses of drugs.

Pfizer denies it is looking to consolidate

Pfizer gathered capabilities info from its US consumer and professional advertising and PR agencies while issuing RFIs to some non-roster agencies, AdWeek reported.

FTC looks into ads for genetic tests

By

The Federal Trade Commission has opened an investigation into the possible deceptive advertising and marketing of DTC genetic tests, according to The New York Times

Survey: pols don't dent DTC credibility

By

All the fury over DTC drug ads emanating from Washington hasn't dented their credibility with consumers, according to Rodale's 11th annual Survey on Consumer Reaction to DTC Advertising of Prescription Drugs.

Merck agrees to TV ad pre-clearance

By

Merck agreed to submit all TV ads to the FDA before running them and to adhere to agency recommendations on them as part of a Vioxx-related settlement.

Four agree to moratorium

By

Four top pharmas told Reps. John Dingell and Bart Stupak that they would refrain from advertising new drugs to consumers for six months after they hit the market.

Ads for gene tests test AMA, California

By

The American Medical Association's House of Delegates adopted a resolution calling for "appropriate organizations" to develop criteria for the advertising of DTC genetic tests

Guidelines on genetic testing at consumers issued

The American College of Medical Genetics issued guidelines on genetic testing aimed at consumers amidst rising DTC advertising of the services.

Cephalon says expenses jumped 30% in Q1

Cephalon reported that selling, general and administrative expenses jumped 30% in the first quarter to $199 million on DTC for narcolepsy drug Provigil (modafinil) and the launch of cancer drug Treanda (bendamustine hydrochloride).

VeriChip Corp. launches first DTC campaign

VeriChip Corp., which makes radio frequency identification devices for healthcare and patient-related needs, launched its first DTC campaign in South Florida at the end of April, rebranding its patient identification system Health Link as part of the effort.

Viagra online ad draws warning

By

The FDA issued a warning letter to Pfizer for not mentioning the risks of impotence pill Viagra in a video ad on CNN.com.

DTC spend down 3% in '07

By

Drug industry spend on consumer advertising dropped 3% in 2007 to $5.15 billion, from $5.31 billion in 2006, but spending on product advertising, particularly TV and print, continued to climb.

Gardasil tops at annual Phame Awards

By

Merck's Gardasil team cleaned up at last month's Phame Awards, winning honors for Best Branded TV, Best Branded Print and Best Integrated Campaign on the strength of its "One less" campaign.

Survey predicts shift in spending away from DTC

DTC spend is slowing, and consumer drug marketers project a shift in spending toward events, rebates/coupons and product placement this year, according to a survey by Cegedim Dendrite.

PhRMA's Tauzin discusses resentment of DTC

PhRMA president Billy Tauzin told The Pink Sheet that DTC ads have been resented because "in many cases, we were talking about new products that they couldn't afford," and said the group's Partnership for Prescription Assistance could help salve that anger.

NEJM study found Zetia uptake rose quicker in US vs. Canada

A New England Journal of Medicine study found Zetia uptake rose much more quickly after introduction in the US than in Canada, and suggested DTC was the main culprit.

Trade group doesn't want 'push' TV, radio or print for Rx info

The European Federation of Pharmaceutical Industries and Associations said it doesn't want "push" TV, radio and print mass media for Rx drug info.

Watchdogs want FDA number in ads

By

Arguing that most Americans don't know about the FDA's adverse events reporting program, Consumers Union said DTC ads should include a toll-free number that patients can use to report side effects to the FDA.

Congress examining anemia drug ads

By

Congress is gearing up yet another investigation of consumer drug advertising.

Jarvik berates NY Times in letter

Dr. Robert Jarvik berated The New York Times in a March 3 letter for calling him a "pitchman" rather than a "spokesman."

Analysts: Sepracor decrease could mean cut in DTC

Sepracor said in reporting Q4 2007 results, 2008 revenues projected to be spent on sales, marketing and distribution expenses would likely decrease around 10% compared with 2007, despite planned launches.

Rx drug ads prompt 1/3 of Americans to request drugs

Rx drug ads prompt nearly a third of Americans to ask their doctor about an advertised drug, and of those who ask, 82% get a prescription, according to a survey of 1,695 US adults by Kaiser Family Foundation, the Harvard School of Public Health and USA Today.

Memorable ads in '07 a tale of bee and beaver

By

Ads featuring an animated bee and a talking beaver were the TV drug spots most recalled by consumers during 2007, according to advertising performance tracking firm IAG Research.

Pfizer cans Lipitor ads, vowing 'clarity'

By

Pfizer pulled Lipitor ads featuring Dr. Robert Jarvik and vowed that it is "committing to ensuring greater clarity in the roles and responsibilities of its spokespeople in its consumer advertising and promotion."

Study says US drug companies spend more on promotion

By

A study by two Canadian researchers says US drug companies spend nearly twice as much on promoting their products ($57.5 billion in 2004) than they spend on research and development ($31.5 billion in 2004).

Consumers Union says ads for devices should carry warnings

By

Consumers Union says ads for implantable medical devices should carry a warning about the possibility of dangerous infections or other adverse events once they are in the body, and that the warning should also cover a device's expected life span before failure occurs.

Congressional investigation uncovers Pfizer's deal with Jarvik

By

A congressional investigation of Pfizer's TV ad campaign for Lipitor, featuring artificial heart inventor Dr. Robert Jarvik, revealed that Pfizer guaranteed Jarvik $1.35 million for the campaign and employed a stunt double to depict him rowing.

Concentric Pharma Advertising launches consumer unit

By

Concentric Pharma Advertising is launching a consumer unit and has recruited former CCA Advertising executive director Mike Devlin to run it.

Sepracor shifts Lunesta DTC biz

By

Sepracor has shifted its Lunesta DTC advertising business from McCann Erickson to Kaplan Thaler Group.

FDA budget bids to revive DTC review

By

The FDA's plan for premarket review of TV ads, scrapped in 2008, might still happen in 2009.

Email Newsletters

MM&M Future Leaders


Register now

Early bird $1,950 before 31 October 2014

*Group discounts available on request 

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.